211 related articles for article (PubMed ID: 18806452)
1. Cosmetic products and their current European regulatory framework.
Rogiers V; Pauwels M
Curr Probl Dermatol; 2008; 36():1-28. PubMed ID: 18806452
[No Abstract] [Full Text] [Related]
2. Challenges related to cosmetic safety assessment in the EU.
Rogiers V; Pauwels M
Curr Probl Dermatol; 2008; 36():29-57. PubMed ID: 18806453
[No Abstract] [Full Text] [Related]
3. The 7th Amendment to the Cosmetics Directive.
Ruet Rossignol M
Altern Lab Anim; 2005 Jul; 33 Suppl 1():19-20. PubMed ID: 16194137
[No Abstract] [Full Text] [Related]
4. Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist.
Pauwels M; Rogiers V
Toxicol Lett; 2004 Jun; 151(1):7-17. PubMed ID: 15177635
[TBL] [Abstract][Full Text] [Related]
5. Is the replacement strategy, as it exists today in the EU for cosmetics, the way forward ?
Rogiers V
Arch Toxicol; 2011 May; 85(5):363-4. PubMed ID: 21528384
[No Abstract] [Full Text] [Related]
6. EU borderline cosmetic products review of current regulatory status.
Morganti P; Paglialunga S
Clin Dermatol; 2008; 26(4):392-7. PubMed ID: 18691521
[TBL] [Abstract][Full Text] [Related]
7. Safety assessment of cosmetic ingredients present in technical information files of finished products.
Rogiers V; Pauwels M
Curr Probl Dermatol; 2008; 36():94-114. PubMed ID: 18806455
[No Abstract] [Full Text] [Related]
8. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
Lodén M; Ungerth L; Serup J
Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
[TBL] [Abstract][Full Text] [Related]
9. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.
Adler S; Basketter D; Creton S; Pelkonen O; van Benthem J; Zuang V; Andersen KE; Angers-Loustau A; Aptula A; Bal-Price A; Benfenati E; Bernauer U; Bessems J; Bois FY; Boobis A; Brandon E; Bremer S; Broschard T; Casati S; Coecke S; Corvi R; Cronin M; Daston G; Dekant W; Felter S; Grignard E; Gundert-Remy U; Heinonen T; Kimber I; Kleinjans J; Komulainen H; Kreiling R; Kreysa J; Leite SB; Loizou G; Maxwell G; Mazzatorta P; Munn S; Pfuhler S; Phrakonkham P; Piersma A; Poth A; Prieto P; Repetto G; Rogiers V; Schoeters G; Schwarz M; Serafimova R; Tähti H; Testai E; van Delft J; van Loveren H; Vinken M; Worth A; Zaldivar JM
Arch Toxicol; 2011 May; 85(5):367-485. PubMed ID: 21533817
[TBL] [Abstract][Full Text] [Related]
10. Towards an integrated in vitro strategy for repeated dose toxicity testing.
Vanhaecke T; Pauwels M; Vinken M; Ceelen L; Rogiers V
Arch Toxicol; 2011 May; 85(5):365-6. PubMed ID: 21512801
[No Abstract] [Full Text] [Related]
11. Safety assessment of cosmetics in Europe. Preface.
Rogiers V; Pauwels M
Curr Probl Dermatol; 2008; 36():XVII-XX. PubMed ID: 19177695
[No Abstract] [Full Text] [Related]
12. The use of non-animal alternatives in the safety evaluations of cosmetics ingredients by the Scientific Committee on Consumer Safety (SCCS).
Vinardell MP
Regul Toxicol Pharmacol; 2015 Mar; 71(2):198-204. PubMed ID: 25555996
[TBL] [Abstract][Full Text] [Related]
13. Critical analysis of the safety assessment of cosmetic ingredients performed at the European level.
Rogiers V; Pauwels M
Curr Probl Dermatol; 2008; 36():58-93. PubMed ID: 18806454
[No Abstract] [Full Text] [Related]
14. [Expected change of direction in Polish law regarding cosmetics].
Karłowski K; Smietanka B; Biernat U; Burzyńska I; Pawłowska K
Rocz Panstw Zakl Hig; 2004; 55(1):21-5. PubMed ID: 15307612
[TBL] [Abstract][Full Text] [Related]
15. The critical review of methodologies and approaches to assess the inherent skin sensitization potential (skin allergies) of chemicals. Part II.
Thyssen JP; Giménez-Arnau E; Lepoittevin JP; Menné T; Boman A; Schnuch A
Contact Dermatitis; 2012 Apr; 66 Suppl 1():25-52. PubMed ID: 22380841
[TBL] [Abstract][Full Text] [Related]
16. Acute toxicity.
Gribaldo L; Gennari A; Blackburn K; Clemedson C; Deguercy A; Meneguz A; Pfaller W; Ruhdel I
Altern Lab Anim; 2005 Jul; 33 Suppl 1():27-34. PubMed ID: 16194139
[No Abstract] [Full Text] [Related]
17. [Sanitary control of cosmetics].
Bonini M; Pellino P; Pilla M
Ig Sanita Pubbl; 2005; 61(3):271-84. PubMed ID: 17206194
[TBL] [Abstract][Full Text] [Related]
18. Genotoxicty and mutagenicity.
Maurici D; Aardema M; Corvi R; Kleber M; Krul C; Laurent C; Loprieno N; Pasanen M; Pfuhler S; Phillips B; Sabbioni E; Sanner T; Vanparys P
Altern Lab Anim; 2005 Jul; 33 Suppl 1():117-30. PubMed ID: 16194145
[No Abstract] [Full Text] [Related]
19. Carcinogenicity.
Maurici D; Aardema M; Corvi R; Kleber M; Krul C; Laurent C; Loprieno N; Pasanen M; Pfuhler S; Phillips B; Prentice D; Sabbioni E; Sanner T; Vanparys P
Altern Lab Anim; 2005 Jul; 33 Suppl 1():177-82. PubMed ID: 16194148
[No Abstract] [Full Text] [Related]
20. The cosmetic technical information file in practice.
Rogiers V; Pauwels M
Curr Probl Dermatol; 2008; 36():115-28. PubMed ID: 18806456
[No Abstract] [Full Text] [Related]
[Next] [New Search]
